Archford Capital Strategies, LLC Pfizer Inc Transaction History

Archford Capital Strategies, LLC

$681 Million
Q3 2024

A detailed history of Archford Capital Strategies, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 17,015 shares of PFE stock, worth $452,939. This represents 0.07% of its overall portfolio holdings.

Number of Shares

17,015

Previous 19,160 11.2%

Holding current value

$452,939

Previous $536,000 8.21%

% of portfolio

0.07%

Previous 0.09%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $59,416 - $67,331	-2,145 Reduced 11.2%	17,015 $492,000
Q2 2024 Jul 17, 2024	SELL	$25.26 - $29.6 $16,797 - $19,684	-665 Reduced 3.35%	19,160 $536,000
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $2,718 - $3,121	105 Added 0.53%	19,825 $550,000
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $362,449 - $470,781	-13,871 Reduced 41.29%	19,720 $567,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $19,671 - $22,993	-613 Reduced 1.79%	33,591 $1.11 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $25,320 - $29,294	-701 Reduced 2.01%	34,204 $1.25 Million
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $107,534 - $139,994	2,730 Added 8.48%	34,905 $1.42 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $86,506 - $112,924	2,072 Added 6.88%	32,175 $0
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $26,343 - $32,158	602 Added 2.04%	30,103 $1.32 Million
Q2 2022 Jul 12, 2022	BUY	$46.53 - $55.17 $135,821 - $161,041	2,919 Added 10.98%	29,501 $1.55 Million
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $141,962 - $175,909	3,103 Added 13.22%	26,582 $1.36 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $96,523 - $143,080	2,336 Added 11.05%	23,479 $1.39 Million
Q3 2021 Oct 14, 2021	BUY	$39.25 - $50.42 $46,746 - $60,050	1,191 Added 5.97%	21,143 $909,000
Q2 2021 Jul 23, 2021	SELL	$35.91 - $40.68 $14,328 - $16,231	-399 Reduced 1.96%	19,952 $781,000
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $743,176 - $838,154	-22,191 Reduced 52.16%	20,351 $765,000
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $27,679 - $35,197	827 Added 1.98%	42,542 $1.58 Million
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $30,257 - $35,499	953 Added 2.34%	41,715 $1.53 Million
Q2 2020 Jul 24, 2020	SELL	$30.12 - $36.54 $7,530 - $9,135	-250 Reduced 0.61%	40,762 $1.33 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $309,277 - $441,890	-11,442 Reduced 21.81%	41,012 $1.34 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $29,660 - $33,661	901 Added 1.75%	52,454 $2.06 Million
Q3 2019 Oct 23, 2019	BUY	$32.49 - $42.13 $93,441 - $121,165	2,876 Added 5.91%	51,553 $1.85 Million
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $41,750 - $46,876	-1,129 Reduced 2.27%	48,677 $2.11 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $61,012 - $67,032	-1,627 Reduced 3.16%	49,806 $2.12 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $47,625 - $54,298	-1,238 Reduced 2.35%	51,433 $2.25 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $187,723 - $227,697	-5,446 Reduced 9.37%	52,671 $2.32 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $245,404 - $261,625	-7,441 Reduced 11.35%	58,117 $2.11 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $4,914 - $5,701	154 Added 0.24%	65,558 $2.38 Million
Q4 2017 Feb 16, 2018	SELL	$33.26 - $35.29 $26,774 - $28,408	-805 Reduced 1.22%	65,404 $2.37 Million
Q3 2017 Nov 17, 2017	BUY	$31.0 - $34.15 $71,176 - $78,408	2,296 Added 3.59%	66,209 $2.36 Million
Q2 2017 Aug 25, 2017	SELL	N/A	-153 Reduced 0.24%	63,913 $2.15 Million
Q2 2017 Aug 18, 2017	BUY	N/A	58,454 Added 1041.59%	64,066 $1.08 Million
Q2 2017 Aug 18, 2017	BUY	N/A	5,612	5,612 $1,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Pfizer Inc Transaction History